New Strong Sell Stocks for June 5th

ADI CBT CM ENS

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Abiomed, Inc. is involved in the research and development of medical devices to assist or replace the pumping function of the failing heart. The Zacks Consensus Estimate for its current year earnings has been revised 1.3% downward over the last 30 days.

Analog Devices, Inc. (ADI - Free Report) is a designer and manufacturer of integrated circuits (ICs), algorithms, software as well as subsystems. The Zacks Consensus Estimate for its current year earnings has been revised 3.9% downward over the last 30 days.

Cabot Corporation (CBT - Free Report) is the owner and operator of a specialty chemicals and performance materials company. The Zacks Consensus Estimate for its current year earnings has been revised 5.5% downward over the last 30 days.

Canadian Imperial Bank of Commerce (CM - Free Report) is a provider of a variety of financial products and services. The Zacks Consensus Estimate for its current year earnings has been revised 4.6% downward over the last 30 days.

EnerSys (ENS - Free Report) is a manufacturer and distributor of industrial batteries. The Zacks Consensus Estimate for its current year earnings has been revised 5.1% downward over the last 30 days.

View the entire Zacks Rank #5 List.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>